跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
LAMITAN lamotrigine 50 mg dispersible/chewable tablet blister pack
Approved
STANDARD
LAMITAN lamotrigine 50 mg dispersible/chewable tablet blister pack
Arrotex Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
392b643fb32d5937
Company
Arrotex Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
392b643fb32d5937
Product Name
LAMITAN lamotrigine 50 mg dispersible/chewable tablet blister pack
Artg Id
147632
Artg Name
LAMITAN lamotrigine 50 mg dispersible/chewable tablet blister pack
Sponsor
Arrotex Pharmaceuticals Pty Ltd
Company Detail Path
/organization/arrotex-pharmaceuticals-pty-ltd
Artg Date
2008-02-06
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/d85c53b9a56baa11b7d1146489462a25.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/7080df08123f10b2919119d86d7fe8ce.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
392b643fb32d5937
Type
Standard
Back to TGA Approvals
LAMITAN lamotrigine 50 mg dispersible/chewable tablet blister pack - TGA Drug Approval Details
